Max Planck Institute for Molecular Biomedicine
||This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. (February 2013)|
The Max Planck Institute for Molecular Biomedicine was founded on 1 April 2001 in Münster, North Rhine-Westphalia, Germany. It is part of the Max Planck Society. The managing director is Prof. Dr. Dietmar Vestweber.
The Institute was founded on 1 August 2001 in Münster, Germany. Founding director was Prof. Dr. Dietmar Vestweber. In 2004 another department was added (Prof. Dr. Hans Robert Schöler). In the same year, the institute got its current name: Max Planck Institute for Molecular Biomedicine. In 2006 the institute moved to a new and modern building offering more space and equipment. At the end of 2007 another department was added (Prof. Dr. Ralf H. Adams). This department moved from the Cancer Research UK London Research Institute to the MPI.
- Department 1 (Prof. Dr. Dietmar Vestweber): Vascular Cell Biology
- Department 2 (Prof. Dr. Hans Robert Schöler): Cell and Developmental Biology
- Department 3 (Prof. Dr. Ralf H. Adams): Tissue Morphogenesis
Department 1 (Vascular Cell Biology) is concentrating its research on leukocyte migration into inflammatory sites.
Department 2 (Cell and Developmental Biology) works on germline development and pluripotency.
Department 3 (Tissue Morphogenesis) works on how cells make tissue, in particular blood vessels.
- The MPI for Molecular Biomedicine offers a Master of Science and a PhD in Molecular Biomedicine together with the University of Münster. Both degree programmes are taught in English.
|This article about a medical organization or association is a stub. You can help Wikipedia by expanding it.|
|This article about a scientific organization is a stub. You can help Wikipedia by expanding it.|